Synthesis and antiproliferative activity of 6BrCaQ-TPP conjugates for targeting the mitochondrial heat shock protein TRAP1.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
05 Feb 2022
Historique:
received: 04 10 2021
revised: 03 12 2021
accepted: 11 12 2021
pubmed: 25 12 2021
medline: 8 2 2022
entrez: 24 12 2021
Statut: ppublish

Résumé

A series of 6BrCaQ-C

Identifiants

pubmed: 34952432
pii: S0223-5234(21)00901-6
doi: 10.1016/j.ejmech.2021.114052
pii:
doi:

Substances chimiques

3-aminoquinolein-2-one 0
Antineoplastic Agents 0
HSP90 Heat-Shock Proteins 0
Organophosphorus Compounds 0
Quinolones 0
TRAP1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114052

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Clelia Mathieu (C)

Université Paris-Saclay, CNRS, Institut Galien-Paris Saclay, 92296, Châtenay-Malabry, France.

Quentin Chamayou (Q)

Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay, Malabry, France.

Thi Thanh Hyen Luong (TT)

Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay, Malabry, France.

Delphine Naud (D)

Institut Curie, Université PSL, CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer, 91400, Orsay, France; Université Paris-Saclay, CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer, 91400, Orsay, France.

Florence Mahuteau-Betzer (F)

Institut Curie, Université PSL, CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer, 91400, Orsay, France; Université Paris-Saclay, CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer, 91400, Orsay, France.

Mouad Alami (M)

Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay, Malabry, France.

Elias Fattal (E)

Université Paris-Saclay, CNRS, Institut Galien-Paris Saclay, 92296, Châtenay-Malabry, France.

Samir Messaoudi (S)

Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay, Malabry, France.

Juliette Vergnaud-Gauduchon (J)

Université Paris-Saclay, CNRS, Institut Galien-Paris Saclay, 92296, Châtenay-Malabry, France. Electronic address: Samir.messaoudi@u-psud.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH